BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
A. Cervantes, V. Georgoulias, A. Falcone. State of the art treatment for gastric cancer: future directionsEuropean Journal of Cancer Supplements 2004; 2(7): 40 doi: 10.1016/j.ejcsup.2004.04.014
2
CHIARA CARLOMAGNO, ELIDE MATANO, ROBERTO BIANCO, CAROLINA CIMMINIELLO, ANTONELLA PRUDENTE, CLORINDO PAGLIARULO, ANNA CRISPO, LUCIA CANNELLA, ALFONSO DE STEFANO, FRANCESCO PAOLO D’ARMIENTO, SABINO DE PLACIDO. Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factorsExperimental and Therapeutic Medicine 2010; 1(4): 611 doi: 10.3892/etm_00000096
3
Bo Li, Lian Chen, Hong-Liang Luo, Feng-Ming Yi, Yi-Ping Wei, Wen-Xiong Zhang. Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysisWorld Journal of Clinical Cases 2019; 7(5): 600-615 doi: 10.12998/wjcc.v7.i5.600
4
J D Barros-Silva, D Leitão, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, M J Bento, L Santos, P Ferreira, S Rêgo, C Brandão, F Carneiro, C Lopes, F Schmitt, M R Teixeira. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patientsBritish Journal of Cancer 2009; 100(3): 487 doi: 10.1038/sj.bjc.6604885
5
María Sereno Moyano, Javier de Castro Carpeño, Jaime Feliu Batles, Cristóbal Belda Iniesta, Lara Miralles Olmedo, Manuel González Barón. Tratamiento adyuvante del cáncer gástrico resecable: experiencia en un servicio de OncologíaClinical and Translational Oncology 2004; 6(9): 525 doi: 10.1007/BF02712382
6
Edwin P. M. Jansen, Henk Boot, Cornelis J. H. van de Velde, Johanna van Sandick, Annemieke Cats, Marcel Verheij. Early Gastrointestinal CancersRecent Results in Cancer Research 2012; 196: 229 doi: 10.1007/978-3-642-31629-6_16
7
Ahmet Tunceroglu, Salma K Jabbour. Gastric cancer: past accomplishments, present approaches and future aspirationsClinical Practice 2013; 10(1): 47 doi: 10.2217/cpr.12.82
8
Olivier Bouché, Jean Luc Raoul, Franck Bonnetain, Marc Giovannini, Pierre Luc Etienne, Gérard Lledo, Dominique Arsène, Jean Francois Paitel, Véronique Guérin-Meyer, Emmanuel Mitry, Bruno Buecher, Marie Christine Kaminsky, Jean François Seitz, Philippe Rougier, Laurent Bedenne, Chantal Milan. Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803Journal of Clinical Oncology 2004; 22(21): 4319 doi: 10.1200/JCO.2004.01.140
9
Karin Oechsle, Carsten Bokemeyer, Jörg T. Hartmann, Wilfried Budach, Tanja Trarbach, Michael Stahl, Ina Boehlke, Christian Kollmannsberger. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO groupJournal of Cancer Research and Clinical Oncology 2009; 135(2): 163 doi: 10.1007/s00432-008-0463-6
10
Kenji Omura. The Diversity of Gastric Carcinoma2005; : 311 doi: 10.1007/4-431-27713-7_23
11
Meng Ye, Hong-Ming Pan, Hai-Yun Wang, Fang Lou, Wei Jin, Yu Zheng, Jin-Ming Wu. Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancerWorld Journal of Gastroenterology 2004; 10(9): 1372-1374 doi: 10.3748/wjg.v10.i9.1372
12
Saber Amri, Hela Ltifi, Mounir Ben Ayed. A Predictive Visual Analytics Evaluation Approach Based on Adaptive Neuro-Fuzzy Inference SystemThe Computer Journal 2019; 62(7): 977 doi: 10.1093/comjnl/bxy091
13
Josef DVORAK, Bohuslav MELICHAR, Jiri PETERA, Karel KABELAC, Milan VOSMIK, Pavel VESELY, Igor SIRAK, Zdenek ZOUL, Ales RYSKA, Pavel JANDIK. Preoperative neoadjuvant chemoradiation for locally advanced gastric adenocarcinomaReports of Practical Oncology & Radiotherapy 2009; 14(5): 169 doi: 10.1016/S1507-1367(10)60032-6
14
Zhu Yu, Xiaojing Guo, Yicheng Jiang, Lei Teng, Jinwu Luo, Pengfei Wang, Yunsheng Liang, Haitian Zhang. Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysisBreast Cancer 2018; 25(1): 8 doi: 10.1007/s12282-017-0794-8
15
Shu-Liang Zhao, Jing-Yuan Fang. The Role of Postoperative Adjuvant Chemotherapy Following Curative Resection for Gastric Cancer: A Meta-AnalysisCancer Investigation 2008; 26(3): 317 doi: 10.1080/07357900701834686
16
Rafael Diaz-Nieto, Rafael Orti-Rodríguez, Marc Winslet. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD008415.pub2
17
P. Sun, J.-B. Xiang, Z.-Y. Chen. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancerBritish Journal of Surgery 2009; 96(1): 26 doi: 10.1002/bjs.6408
18
Yizhuo Wang, Chang Wang, Huijie Xiao, Chao Niu, Haitao Wu, Haofan Jin, Cheng Yao, Hua He, Huimin Tian, Fujun Han, Dan Li, Wei Han, Jianting Xu, Jingtao Chen, Jiuwei Cui, Wei Li. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancerCancer Medicine 2017; 6(1): 45 doi: 10.1002/cam4.942
19
D. Nitti, J. Wils, J. Guimaraes Dos Santos, G. Fountzilas, P. F. Conte, C. Sava, A. Tres, R. C. Coombes, D. Crivellari, A. Marchet, E. Sanchez, J. M. Bliss, J. Homewood, M. L. Couvreur, E. Hall, B. Baron, E. Woods, M. Emson, E. Van Cutsem, M. Lise. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGAnnals of Oncology 2006; 17(2): 262 doi: 10.1093/annonc/mdj077
20
Hei-Cheul Jeung, Sun Young Rha, Sang Joon Shin, Joong Bae Ahn, Jae Kyung Roh, Chan Hee Park, Sung Hoon Noh, Hyun Cheol Chung. Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trialsCancer Chemotherapy and Pharmacology 2009; 63(5): 919 doi: 10.1007/s00280-008-0808-5
21
Howard Silberman. Perioperative adjunctive treatment in the management of operable gastric cancerJournal of Surgical Oncology 2005; 90(3): 174 doi: 10.1002/jso.20226
22
Zhe-Yi Han, Kai-Chun Wu, Feng-Tian He, Quan-Li Han, Yong-Zhan Nie, Ying Han, Xiao-Nan Liu, Jian-Yong Zheng, Mei-Hong Xu, Tao Lin, Dai-Ming Fan. Screening and identification of mimotope of gastric cancer associated antigen MGb1-AgWorld Journal of Gastroenterology 2003; 9(9): 1920-1924 doi: 10.3748/wjg.v9.i9.1920
23
Jun Nakamura, Yoshihiko Kitajima, Keita Kai, Kazuyoshi Hashiguchi, Masatsugu Hiraki, Hirokazu Noshiro, Kohji Miyazaki. HIF-1α is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapyInternational Journal of Cancer 2009; 127(5): 1158 doi: 10.1002/ijc.25129
24
Greg Knight, Craig C. Earle, Roxanne Cosby, Natalie Coburn, Youssef Youssef, Richard Malthaner, Rebecca K. S. Wong. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North AmericaGastric Cancer 2013; 16(1): 28 doi: 10.1007/s10120-012-0148-3
25
Johan L. Dikken, Cornelis J.H. van de Velde, Daniel G. Coit, Manish A. Shah, Marcel Verheij, Annemieke Cats. Treatment of resectable gastric cancerTherapeutic Advances in Gastroenterology 2012; 5(1): 49 doi: 10.1177/1756283X11410771
26
Johan L. Dikken, Jurriën Stiekema, Cornelis J. H. van de Velde, Marcel Verheij, Annemieke Cats, Michel W. J. M. Wouters, Johanna W. van Sandick. Quality of Care Indicators for the Surgical Treatment of Gastric Cancer: A Systematic ReviewAnnals of Surgical Oncology 2013; 20(2): 381 doi: 10.1245/s10434-012-2574-1
27
Giulia Manzini, Doris Henne-Bruns, Michael Kremer. Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trialsBMJ Open Gastroenterology 2017; 4(1): e000138 doi: 10.1136/bmjgast-2017-000138
28
C. Brigand, C. Arvieux, F.N. Gilly, O. Glehen. Treatment of Peritoneal Carcinomatosis in Gastric CancersDigestive Diseases 2004; 22(4): 366 doi: 10.1159/000083600
29
I.A. Freires, I.C.G. Silva, L.A. Alves, L.M.D. Bezerra, R.D. Castro. Clinical applicability of natural product(s)-containing mouthwashes as adjunctive treatment of biofilm-induced gingivitis: a systematic reviewRevista Brasileira de Plantas Medicinais 2012; 14(4): 700 doi: 10.1590/S1516-05722012000400019
30
Zhen Zhang. Radiation OncologyMedical Radiology 2008; : 189 doi: 10.1007/978-3-540-77385-6_13
31
Xi-Mei Chen, Guo-Yu Chen, Zhi-Rong Wang, Feng-Shang Zhu, Xiao-Lei Wang, Xia Zhang. Detection of micrometastasis of gastric carcinoma in peripheral blood circulationWorld Journal of Gastroenterology 2004; 10(6): 804-808 doi: 10.3748/wjg.v10.i6.804
32
Christopher Jackson, Naureen Starling, Yu Jo Chua, David Cunningham. Pharmacotherapy for Oesophagogastric CancerDrugs 2007; 67(17): 2539 doi: 10.2165/00003495-200767170-00006
33
Irlan Freires, Carina Denny, Bruna Benso, Severino de Alencar, Pedro Rosalen. Antibacterial Activity of Essential Oils and Their Isolated Constituents against Cariogenic Bacteria: A Systematic ReviewMolecules 2015; 20(4): 7329 doi: 10.3390/molecules20047329
34
Jaffer Ajani. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancersCancer 2006; 107(2): 221 doi: 10.1002/cncr.21986
35
Carlo Barone, Michele Basso, Giovanni Schinzari, Carmelo Pozzo, Nunziatina Trigila, Ettore D'Argento, Michela Quirino, Antonio Astone, Alessandra Cassano. Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancerGastric Cancer 2007; 10(2): 104 doi: 10.1007/s10120-007-0415-x
36
Thales Paulo BATISTA, Candice Amorim de Araujo Lima SANTOS, Gustavo Fernandes Godoy ALMEIDA. PERIOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCERArquivos de Gastroenterologia 2013; 50(3): 236 doi: 10.1590/S0004-28032013000200042
37
Daniel Coit. Adjuvant Therapy for Gastric CancerJournal of the American College of Surgeons 2007; 205(4): S54 doi: 10.1016/j.jamcollsurg.2007.06.329
38
Vincenzo Catalano, Roberto Labianca, Giordano D. Beretta, Gemma Gatta, Filippo de Braud, Eric Van Cutsem. Gastric cancerCritical Reviews in Oncology/Hematology 2005; 54(3): 209 doi: 10.1016/j.critrevonc.2005.01.002
39
Marco Torregroza, Cristina Guarnizo. Enfoque terapéutico del cáncer gástrico. Revisión de la literaturaRevista Colombiana de Cancerología 2011; 15(1): 30 doi: 10.1016/S0123-9015(11)70078-6
40
Xiao-Long Chen, Xin-Zu Chen, Chen Yang, Yan-Biao Liao, He Li, Li Wang, Kun Yang, Ka Li, Jian-Kun Hu, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Wael El-Rifai. Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-AnalysisPLoS ONE 2013; 8(4): e60320 doi: 10.1371/journal.pone.0060320
41
Vincenzo Catalano, Roberto Labianca, Giordano D. Beretta, Gemma Gatta, Filippo de Braud, Eric Van Cutsem. Gastric cancerCritical Reviews in Oncology/Hematology 2009; 71(2): 127 doi: 10.1016/j.critrevonc.2009.01.004
42
C. Focan, F. Kreutz, L. Longrée, M.-P. Graas, N. Moeneclaey, G. Demolin, D. Focan-Henrard. Intérêt de la chronothérapie dans le traitement pluridisciplinaire des cancers de l'œsophage et de l'estomacPathologie Biologie 2007; 55(3-4): 181 doi: 10.1016/j.patbio.2006.12.002
43
Li-Duan Zheng, Qiang-Song Tong, Liang Wang, Jun Liu, Wei Qian. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cellsWorld Journal of Gastroenterology 2005; 11(1): 79-83 doi: 10.3748/wjg.v11.i1.79
44
Theodoros Foukakis, Lars Lundell, Michael Gubanski, Pehr A. Lind. Advances in the treatment of patients with gastric adenocarcinomaActa Oncologica 2007; 46(3): 277 doi: 10.1080/02841860701218634
45
Scott A Hundahl. Evidence-Based Recommendations for Local-Regional Control of Gastric CancerCancer Investigation 2005; 23(4): 352 doi: 10.1081/CNV-58885
46
Johan L. Dikken, Annemieke Cats, Marcel Verheij, Cornelis J.H. van de Velde. Randomized trials and quality assurance in gastric cancer surgeryJournal of Surgical Oncology 2013; 107(3): 298 doi: 10.1002/jso.23080
47
E. Van Cutsem. Thérapeutique du cancer2011; : 341 doi: 10.1007/978-2-8178-0021-9_22
48
C. Brézault-Bonnet, S. Dominguez-Tinajero. Les cancers digestifsOncologie Pratique 2006; : 109 doi: 10.1007/2-287-30874-1_6
49
Tao Ma, Zheng-Gang Zhu, Yu-Bao Ji, Yi Zhang, Ying-Yan Yu, Bing-Ya Liu, Hao-Ran Yin, Yan-Zhen Lin. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2’-deoxyuridineWorld Journal of Gastroenterology 2004; 10(2): 172-176 doi: 10.3748/wjg.v10.i2.172